GO:0061714 folic acid receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061714 (folic acid receptor activity) is a molecular function defined as the selective binding of extracellular folic acid and its delivery into the cell via endocytosis.
• Folate receptors, particularly FOLR1 (folate receptor alpha), mediate high-affinity binding and internalization of folic acid, enabling targeted delivery of folate-conjugated therapeutics.
• Folic acid receptor activity is exploited in cancer research for tumor-selective drug delivery, as folate receptors are overexpressed in several malignancies.
• Folic acid binding to FOLR1 can activate oncogenic signaling pathways, including STAT3, linking this receptor activity to cancer cell proliferation and migration.
• Experimental models for studying folic acid receptor activity include knockout, point-mutation, knock-in, and overexpression cell lines, as well as folate-conjugated nanoparticle systems.
• Dysregulated folic acid receptor activity is implicated in breast, prostate, liver, and kidney pathologies, making it a target for therapeutic intervention.
Description
Folic acid receptor activity (GO:0061714) is a molecular function that enables cells to selectively bind extracellular folic acid and internalize it through endocytosis. This activity is primarily mediated by folate receptors, such as FOLR1 (folate receptor alpha), which exhibit high affinity for folic acid and its reduced derivatives. The receptor-ligand complex is internalized via clathrin-coated pits, delivering folate into the endosomal compartment, where it can be released or processed for cellular utilization. This process is critical for one-carbon metabolism, nucleotide synthesis, and methylation reactions, and it has become a focal point in cancer research due to the overexpression of folate receptors in several tumor types. Understanding the molecular mechanism of folic acid receptor activity is essential for developing targeted therapies and diagnostic tools.
folic acid receptor activity At A Glance
| GO ID | GO:0061714 |
|---|---|
| GO term | folic acid receptor activity |
| Ontology | molecular_function |
| Synonym | folate receptor activity |
| Definition | Combining selectively with extracellular folic acid and delivering it into the cell via endocytosis. |
| Major function | Mediates high-affinity binding and endocytic uptake of folic acid. |
| Representative gene | FOLR1 (folate receptor alpha) |
| Associated process | Receptor-mediated endocytosis; folate transport |
| Disease relevance | Cancer (breast, prostate, liver), kidney fibrosis |
What Is GO:0061714?
Folic acid receptor activity (GO:0061714) is defined as the molecular function of combining selectively with extracellular folic acid and delivering it into the cell via endocytosis. This activity involves a cell-surface receptor that binds folic acid with high affinity, followed by internalization of the receptor-ligand complex. The synonym for this term is folate receptor activity. It is a molecular function that facilitates the uptake of folate, a vital cofactor for one-carbon transfer reactions, and is distinct from folate transporters that do not use endocytosis.
Why Is folic acid receptor activity Important in Cell Biology?
Folic acid receptor activity is crucial for cellular folate uptake, which is required for DNA synthesis, repair, and methylation. Its overexpression in cancer cells makes it a prime target for tumor-selective drug delivery and imaging. Moreover, folic acid binding to its receptor can trigger signaling cascades that promote oncogenesis, such as STAT3 activation. Understanding this activity is therefore vital for both basic cell biology and translational medicine.
• Enables high-affinity folate uptake essential for one-carbon metabolism.
• Overexpressed in breast, prostate, and liver cancers, enabling targeted therapy.
• Mediates endocytosis of folate-conjugated drugs, siRNAs, and nanoparticles.
• Activates oncogenic signaling pathways like STAT3 upon folic acid binding.
• Involved in kidney fibrosis through C5a receptor 1-mediated myeloid cell activation.
• Regulates cancer cell proliferation and migration via progesterone receptor activation.
• Provides a mechanism for gene silencing through folate-siRNA conjugates.
• Serves as a biomarker for folate receptor-targeted imaging and therapy.
• Disruption of receptor functionality can lead to dual therapeutic anti-cancer effects.
• Folic acid modification enhances photodynamic activity of porphyrin-polysaccharide complexes.
Molecular Mechanism of folic acid receptor activity
Folic Acid Binding and Receptor Specificity
In simple terms: The receptor grabs folic acid from outside the cell with high specificity.
Folic acid receptor activity begins with the selective binding of extracellular folic acid to the folate receptor, primarily FOLR1. This binding is high-affinity and specific, allowing cells to compete for folate even at low concentrations. The receptor's ligand-binding pocket recognizes the pteridine ring and glutamate moiety of folic acid, ensuring discrimination from other folates.
Endocytosis and Intracellular Delivery
In simple terms: After grabbing folic acid, the cell engulfs the receptor and brings it inside.
Upon folic acid binding, the receptor-ligand complex is internalized via endocytosis, often through clathrin-coated pits. This process delivers folic acid into the endosomal compartment, where the acidic environment promotes ligand release. The receptor can then recycle back to the cell surface, maintaining continuous uptake.
Signaling Activation by Folic Acid Receptor
In simple terms: Folic acid binding can also turn on growth signals inside the cell.
Beyond transport, folic acid receptor activity can activate intracellular signaling. For example, folic acid binding to FOLR1 mediates activation of the pro-oncogene STAT3, which promotes cell proliferation and survival. This signaling is independent of folate transport and highlights the receptor's dual role in metabolism and oncogenesis.
Regulation of Receptor Expression and Function
In simple terms: Cells control how much receptor they make and how active it is.
Folic acid receptor activity is regulated at multiple levels, including receptor expression, recycling, and post-translational modifications. Progesterone receptor activation is essential for folic acid-regulated cancer cell proliferation and migration, indicating hormonal cross-talk. Additionally, folate-conjugated nanoparticles can disrupt receptor functionality, leading to anti-cancer effects.
Key Genes Involved in GO:0061714 folic acid receptor activity
The following genes and proteins are central to folic acid receptor activity and its downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FOLR1 | High-affinity folate receptor alpha; mediates binding and endocytosis of folic acid | Overexpressed in cancers; target for folate-conjugated therapeutics |
| FOLR2 | Folate receptor beta; expressed in placenta and hematopoietic cells | Potential role in immune regulation and cancer |
| STAT3 | Signal transducer and activator of transcription 3; activated downstream of FOLR1 | Oncogenic signaling; promotes proliferation and survival |
| PGR | Progesterone receptor; essential for folic acid-regulated proliferation | Hormonal regulation of cancer cell growth |
| C5AR1 | C5a receptor 1; mediates folic acid-induced kidney fibrosis | Inflammatory signaling in kidney disease |
| SLC19A1 | Reduced folate carrier; transports reduced folates but not via endocytosis | Distinct from folic acid receptor activity |
| GPI | Glycosylphosphatidylinositol anchor; attaches FOLR1 to membrane | Essential for receptor localization and function |
| CLTC | Clathrin heavy chain; involved in endocytosis of folate receptor | Endocytic machinery for receptor internalization |
| CBL | E3 ubiquitin ligase; may regulate receptor recycling | Potential regulator of folate receptor stability |
| RAB5 | Small GTPase; regulates early endosome fusion | Endosomal trafficking of folate receptor |
| RAB7 | Late endosomal marker; involved in receptor degradation | Receptor downregulation |
| ATP6V1 | V-ATPase subunit; acidifies endosomes | Promotes ligand release from receptor |
| FOLH1 | Prostate-specific membrane antigen; folate hydrolase | Related to folate metabolism in prostate cancer |
| MTHFR | Methylenetetrahydrofolate reductase; folate metabolism | Downstream of folate uptake |
| TYMS | Thymidylate synthase; folate-dependent DNA synthesis | Target of antifolates |
| DHFR | Dihydrofolate reductase; folate metabolism | Methotrexate target |
| GART | Glycinamide ribonucleotide transformylase; folate-dependent purine synthesis | Folate utilization |
| MTR | Methionine synthase; folate-dependent methylation | One-carbon metabolism |
How Is folic acid receptor activity Regulated?
Folic acid receptor activity is regulated by receptor expression levels, recycling efficiency, and post-translational modifications. Progesterone receptor activation is essential for folic acid-regulated cancer cell proliferation and migration, indicating hormonal control. Additionally, folate-conjugated nanoparticles can disrupt receptor functionality, leading to dual therapeutic anti-cancer effects. The receptor's endocytic cycle is modulated by Rab GTPases and endosomal acidification.
folic acid receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FOLR1 | Breast and prostate cancer | FOLR1 knockout and overexpression in MCF-7 and PC-3 cells |
| STAT3 | Oncogenic signaling in cancer | STAT3 point-mutation knock-in to assess folic acid-induced activation |
| C5AR1 | Kidney fibrosis | C5ar1 knockout mouse model with folic acid-induced fibrosis |
| PGR | Hormone-responsive cancer | PGR knockout in breast cancer cells treated with folic acid |
| FOLR1 | Liver cancer (HepG2) | FOLR1 knock-in in HepG2 cells for folate-targeted immunotherapy |
Folic Acid Receptor Activity in Cancer
Folic acid receptor activity is hijacked in many cancers to support rapid proliferation. FOLR1 is overexpressed in breast, prostate, and liver cancers, where it mediates uptake of folate-conjugated drugs and siRNAs. Folic acid binding also activates STAT3, promoting oncogenesis. Targeting this activity with folate-modified nanoparticles has shown anti-cancer potential in 2D and 3D models.
Folic Acid Receptor Activity in Kidney Fibrosis
Folic acid-mediated fibrosis is driven by C5a receptor 1-mediated activation of kidney myeloid cells. This highlights a role for folic acid receptor activity in inflammatory kidney disease, where folic acid overload triggers fibrotic responses.
Folic Acid Receptor Activity in Liver Disease
Caffeine-folic acid-loaded chitosan nanoparticles combined with methotrexate show immunotherapy potential in HepG2 liver cancer cells by targeting adenosine A2A receptor downstream cascade. This suggests that folic acid receptor activity can be exploited for liver cancer therapy.
From folic acid receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FOLR1 mediate folic acid uptake? | FOLR1 knockout cell line (e.g., HeLa) |
| Does folic acid binding activate STAT3? | STAT3 point-mutation knock-in (Y705F) |
| Can folate-conjugated drugs target cancer cells? | FOLR1 overexpression in breast cancer cells |
| What is the role of C5aR1 in folic acid-induced fibrosis? | C5ar1 knockout mouse |
| How does progesterone receptor regulate folic acid response? | PGR knockout and overexpression in cancer cells |
| Can folate-siRNA conjugates silence genes? | FOLR1 knock-in in cells lacking endogenous receptor |
How to Study the folic acid receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding assay | Affinity and specificity of folic acid binding | Characterizing FOLR1 variants |
| Confocal microscopy | Internalization and endosomal trafficking | Visualizing folate receptor endocytosis |
| Flow cytometry | Cell surface receptor levels and uptake | Quantifying FOLR1 expression |
| CRISPR knockout | Loss of receptor function | Validating FOLR1 as the mediator of uptake |
| Western blot | STAT3 phosphorylation | Assessing folic acid-induced signaling |
| Nanoparticle synthesis | Folate-conjugated drug delivery | Targeted cancer therapy |
| siRNA conjugation | Gene silencing efficiency | Folate receptor-mediated siRNA delivery |
| Mouse fibrosis model | Kidney fibrosis induction | Testing C5aR1 involvement |
Binding and Uptake Assays
Folic acid receptor activity can be measured using radiolabeled or fluorescently labeled folic acid binding assays, followed by internalization studies. Flow cytometry and confocal microscopy quantify receptor-mediated endocytosis.
Genetic Knockout and Knock-in Models
CRISPR-Cas9 knockout of FOLR1 and subsequent rescue with wild-type or mutant receptors allows dissection of binding versus signaling functions. Knock-in of tagged receptors enables tracking of endocytic trafficking.
Nanoparticle-Based Delivery Systems
Folic acid-modified nanoparticles are used to study targeted delivery and therapeutic efficacy. These systems exploit folic acid receptor activity for selective uptake in cancer cells.
Signaling Pathway Analysis
Western blotting and luciferase reporter assays assess downstream signaling, such as STAT3 activation, following folic acid stimulation. Progesterone receptor involvement is studied via hormone depletion and receptor antagonists.
How CRISPR Can Be Used to Study GO:0061714 folic acid receptor activity
Knockout
CRISPR knockout of FOLR1 abolishes folic acid receptor activity, providing a clean background to study its role in folate uptake and signaling. Such models are essential for validating receptor specificity and for testing targeted therapeutics.
Point Mutation
Point mutations in FOLR1 can disrupt ligand binding or endocytosis. For example, mutating residues in the ligand-binding pocket or GPI anchor attachment site clarifies structure-function relationships.
Knock-in
Knock-in of tagged FOLR1 (e.g., GFP or HA) allows real-time tracking of receptor trafficking and endocytosis in live cells. Knock-in of disease-associated variants can model altered receptor activity.
Overexpression
Overexpression of FOLR1 in cancer cell lines enhances folic acid uptake and sensitivity to folate-conjugated drugs, mimicking the overexpression seen in tumors. This model is useful for screening targeted therapies.
How EDITGENE Supports folic acid receptor activity Research
Researchers studying folic acid receptor activity-related genes often need to determine whether a candidate gene is causally involved in folate uptake, signaling, or disease progression. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for folic acid receptor activity research.
Frequently Asked Questions About folic acid receptor activity
What is folic acid receptor activity?
Folic acid receptor activity (GO:0061714) is a molecular function where a cell-surface receptor binds extracellular folic acid and internalizes it via endocytosis.
What genes are involved in folic acid receptor activity?
Key genes include FOLR1 (folate receptor alpha), FOLR2, and downstream signaling molecules like STAT3 and PGR.
How is folic acid receptor activity used in cancer therapy?
Folate receptors are overexpressed in many cancers, allowing targeted delivery of folate-conjugated drugs, siRNAs, and nanoparticles.
What is the role of FOLR1 in folic acid uptake?
FOLR1 binds folic acid with high affinity and mediates its endocytic uptake, which is essential for one-carbon metabolism.
Can folic acid receptor activity activate signaling pathways?
Yes, folic acid binding to FOLR1 can activate STAT3, promoting cell proliferation and survival.
What diseases are associated with folic acid receptor activity?
It is implicated in breast, prostate, and liver cancers, as well as kidney fibrosis.
How can I study folic acid receptor activity in the lab?
Common methods include radioligand binding assays, confocal microscopy, CRISPR knockout, and nanoparticle-based delivery systems.
What are folate-conjugated nanoparticles?
These are nanoparticles modified with folic acid to target folate receptor-overexpressing cells for drug delivery.
Is folic acid receptor activity the same as folate transport?
No, folic acid receptor activity specifically involves endocytosis, whereas other transporters like SLC19A1 use different mechanisms.
How does progesterone receptor relate to folic acid receptor activity?
Progesterone receptor activation is essential for folic acid-regulated cancer cell proliferation and migration.
Conclusion
Folic acid receptor activity (GO:0061714) is a specialized molecular function that mediates high-affinity folate uptake and signaling, with profound implications for cancer biology and targeted therapy. Its overexpression in tumors and ability to internalize folate-conjugated therapeutics make it a versatile target for drug delivery and imaging. Continued research using CRISPR-engineered models will further elucidate its mechanistic roles and therapeutic potential.
References
- 1. Sahu RK et al.. 2022. Folic acid-mediated fibrosis is driven by C5a receptor 1-mediated activation of kidney myeloid cells.. Am J Physiol Renal Physiol 322(6):F597-F610 PMID: 35379003
- 2. Nishimura K et al.. 2024. Improving the Photodynamic Activity of Water-Soluble Porphyrin-Polysaccharide Complexes by Folic Acid Modification.. ChemMedChem 19(20):e202400268 PMID: 38924356
- 3. Law S et al.. 2020. Folic acid-modified celastrol nanoparticles: synthesis, characterization, anticancer activity in 2D and 3D breast cancer models.. Artif Cells Nanomed Biotechnol 48(1):542-559 PMID: 32054336
- 4. Hamed A et al.. 2023. Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.. BMC Complement Med Ther 23(1):384 PMID: 37891562
- 5. Wang HC et al.. 2023. Activation of progesterone receptor is essential for folic acid-regulated cancer cell proliferation and migration.. J Nutr Biochem 112:109205 PMID: 36455835
- 6. Hansen MF et al.. 2015. Folic acid mediates activation of the pro-oncogene STAT3 via the Folate Receptor alpha.. Cell Signal 27(7):1356-68 PMID: 25841994
- 7. Salim L et al.. 2020. Targeted delivery and enhanced gene-silencing activity of centrally modified folic acid-siRNA conjugates.. Nucleic Acids Res 48(1):75-85 PMID: 31777918
- 8. DeCarlo A et al.. 2021. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer.. Bioconjug Chem 32(3):512-522 PMID: 33556240
